Literature DB >> 17992549

Comparison and evaluation of four commercial kits relative to an in-house immunofluorescence test for detection of antibodies against Legionella pneumophila.

P Elverdal1, C S Jørgensen, S A Uldum.   

Abstract

Four commercially available kits from (1) Focus Diagnostics, (2) SERION, (3) Zeus and (4) Vircell for detection of antibodies to Legionella pneumophila were evaluated with panels of sera from patients with proven Legionella infection (n = 81) and/or other bacterial infections (n = 75). An in-house indirect Legionella immunofluorescence antibody test (IF test) was used as reference. All sera from the laboratory-proven Legionella pneumophila cases [culture, urinary antigen test and/or polymerase chain reaction] of Legionella infection were found to be positive by the in-house IF test. The relative sensitivity for Focus Diagnostics, SERION, Zeus and Vircell kits was 81.5, 76.5, 68.8 and 62.5%, respectively, and the false-positive rate was 16.0, 5.6, 29.0 and 2.7%, respectively. The in-house IF test had a false-positive rate of 4.0%. It was found that none of the four commercial kits were as sensitive and specific as the in-house IF test.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17992549     DOI: 10.1007/s10096-007-0410-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Detection of Legionella pneumophila antigen in urine samples by the BinaxNOW immunochromatographic assay and comparison with both Binax Legionella Urinary Enzyme Immunoassay (EIA) and Biotest Legionella Urin Antigen EIA.

Authors:  Jürgen H Helbig; Søren A Uldum; P Christian Lück; Timothy G Harrison
Journal:  J Med Microbiol       Date:  2001-06       Impact factor: 2.472

2.  Reference values for the SERION classic ELISA for detecting Legionella pneumophila antibodies.

Authors:  H C Boshuizen; J W Den Boer; H de Melker; J F P Schellekens; M F Peeters; J A van Vliet; M A E Conyn-van Spaendonck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-14       Impact factor: 3.267

3.  A multiplex PCR for detection of Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella pneumophila, and Bordetella pertussis in clinical specimens.

Authors:  Erin A McDonough; Christopher P Barrozo; Kevin L Russell; David Metzgar
Journal:  Mol Cell Probes       Date:  2005-10       Impact factor: 2.365

4.  Evaluation of Vircell enzyme-linked immunosorbent assay and indirect immunofluorescence assay for detection of antibodies against Legionella pneumophila.

Authors:  Bram M W Diederen; Jan A J W Kluytmans; Marcel F Peeters
Journal:  Clin Vaccine Immunol       Date:  2006-03

5.  Development and evaluation of Chlamylege, a new commercial test allowing simultaneous detection and identification of Legionella, Chlamydophila pneumoniae, and Mycoplasma pneumoniae in clinical respiratory specimens by multiplex PCR.

Authors:  C Ginevra; C Barranger; A Ros; O Mory; J-L Stephan; F Freymuth; M Joannès; B Pozzetto; F Grattard
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 6.  Laboratory diagnosis of infections caused by legionellae.

Authors:  P H Edelstein
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

7.  Comparison of two commercial enzyme-linked immunosorbent assays with an immunofluorescence assay for detection of Legionella pneumophila types 1 to 6.

Authors:  Annette K Malan; Thomas B Martins; Troy D Jaskowski; Harry R Hill; Christine M Litwin
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  Indirect immunofluorescence test for serodiagnosis of Legionnaires disease: evidence for serogroup diversity of Legionnaires disease bacterial antigens and for multiple specificity of human antibodies.

Authors:  H W Wilkinson; B J Fikes; D D Cruce
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

9.  Study of cross-reaction between Coxiella burnetii and Legionella pneumophila using indirect immunofluorescence assay and immunoblotting.

Authors:  J P Finidori; D Raoult; N Bornstein; J Fleurette
Journal:  Acta Virol       Date:  1992-10       Impact factor: 1.162

10.  Cross-reactions between Legionella pneumophila (serogroup 1) and twenty-eight other bacterial species, including other members of the family Legionellaceae.

Authors:  M T Collins; F Espersen; N Høiby; S N Cho; A Friis-Møller; J S Reif
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

View more
  4 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Seroepidemiological study after a long-distance industrial outbreak of legionnaires' disease.

Authors:  E Wedege; T Bergdal; K Bolstad; D A Caugant; J Efskind; H E Heier; A Kanestrøm; B H Strand; I S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2009-02-18

3.  Review Global seroprevalence of legionellosis - a systematic review and meta-analysis.

Authors:  Frances F Graham; Simon Hales; Paul S White; Michael G Baker
Journal:  Sci Rep       Date:  2020-04-30       Impact factor: 4.379

4.  Legionella antibodies in a Danish hospital staff with known occupational exposure.

Authors:  M Rudbeck; S Viskum; K Mølbak; S A Uldum
Journal:  J Environ Public Health       Date:  2009-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.